Posted by: drchasrani on: June 14, 2012
CABG remains the main stay treatment for triple vessel disease. Not only it helps revascularisation but also prevents MI, thus increasing lifespan. Team@CMHF
Posted by: drchasrani on: June 14, 2012
It has been observed that there are many patients of hyertrophic cardiomyopathy than thought. Hence a new guide line is suggested for treating them. Team@CMHF
Posted by: drchasrani on: June 14, 2012
A study found that tripling the standard dose of clopidogrel was able to overcome genetic resistance to the drug. No major untoward effects were seen during the study. […]